VANCOUVER, BC, March 27, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it has launched the Numinus Certification Pathway – a collection of psychedelic-assisted therapy (“PAT”) training courses uniquely…


Previous articleDispatch from ECNP New Frontiers: Psychedelics (Psychedelic Bulletin #134)
Next articleReunion Neuroscience Abstract Accepted for Poster Presentation at 2023 ASCP Annual Meeting